US2012183542A1PendingUtilityA1

Treating neurological disorders

56
Assignee: BURKLY LINDA CPriority: Feb 17, 2005Filed: Aug 31, 2011Published: Jul 19, 2012
Est. expiryFeb 17, 2025(expired)· nominal 20-yr term from priority
A61K 38/1793G01N 2800/2814A61P 25/00G01N 33/6896A61P 29/00G01N 2800/2835A61P 25/16A61P 25/28A61K 39/3955A61P 25/14
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods of treating neuronal disorders, such as mechanical neuronal traumas and neurodegenerative disorders, with TWEAK or a TWEAK receptor blocking agents are presented.

Claims

exact text as granted — not AI-modified
1 - 90 . (canceled) 
     
     
         91 . A method for treating a human subject having inflammation associated with a neuronal disorder comprising administering to the subject a therapeutically effective amount an agent that blocks a TWEAK/TWEAK-R interaction or activity, wherein the agent is an antibody or antigen-binding fragment thereof that binds to TWEAK and/or a TWEAK receptor, or a soluble form of a TWEAK receptor. 
     
     
         92 . The method of  claim 91 , wherein the agent reduces the ability of TWEAK to bind to Fn14. 
     
     
         93 . The method of  claim 91 , wherein the agent is an antibody or antigen-binding fragment thereof that binds to human TWEAK. 
     
     
         94 . The method of  claim 91 , wherein the antibody is a full-length IgG. 
     
     
         95 . The method of  91 , wherein the antibody consists of an antigen binding fragment of an IgG. 
     
     
         96 . The method of  claim 91 , wherein the antibody is a human or humanized antibody. 
     
     
         97 . The method of  claim 91 , wherein the agent is a soluble form of a TWEAK receptor. 
     
     
         98 . The method of  claim 91 , wherein the soluble form of the TWEAK receptor is fused with an antibody Fc region. 
     
     
         99 . The method of  claim 91 , wherein the agent is administered in an amount or for a time sufficient to reduce the amount of neuronal cell damage in the subject, relative to a similarly affected, but untreated subject. 
     
     
         100 . The method of  claim 91 , wherein the agent is administered in combination with another treatment for the neuronal disorder. 
     
     
         101 . A container comprising an agent that blocks a TWEAK/TWEAK-R interaction or activity, and a label with instructions for use of the agent in treating a neuronal disorder.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.